# A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection

> **NCT02391805** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 31 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Placebo
- **DRUG:** RO6864018
- **DRUG:** Tenofovir

## Key facts

- **NCT ID:** NCT02391805
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-17
- **Primary completion:** 2017-10-16
- **Final completion:** 2017-10-16
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02391805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02391805, "A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02391805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*